SFX by Ex Libris Inc.

Title:	Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Source:	Nature Genetics [1061-4036] Jiao, Yuchen yr:2013

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ji, H. "Targeting the RAS pathway in melanoma." Trends in molecular medicine 18.1 (2012): 27-35.
description	2.	Solit, Antoni A. "Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence." Cancer research 74.8 (2014): 2340-2350.
description	3.	Choi, S. "Aggressive B cell lymphomas of the gastrointestinal tract: clinicopathologic and genetic analysis." Virchows Archiv 459.5 (2011): 495-502.
description	4.	Borger, Darrell R. "Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping." The oncologist 17.1 (2011): 72-79.
description	5.	Wei, X. "Exome sequencing identifies GRIN2A as frequently mutated in melanoma." Nature Genetics 43.5 (2011): 442-6.
description	6.	Yan, Xiao-Jing J. "Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia." Nature Genetics 43.4 (2011): 309-315.
description	7.	Kwong, Lawrence N. "The Brothers RAF." Cell 140.2 (2010): 180-182.
description	8.	Kinnaird, A. "Metabolic control of epigenetics in cancer." Nature Reviews. Cancer 16.11 (2016): 694-707.
description	9.	Manca, A. "Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas." Journal of translational medicine 13.1 (2015): 37-.
description	10.	Iyer, G. "Prevalence and Co-Occurrence of Actionable Genomic Alterations in High-Grade Bladder Cancer." Journal of clinical oncology 31.25 (2013): 3133-3140.
description	11.	Arhi, C. "Use of a silver dressing for management of an open abdominal wound complicated by an enterocutaneous fistula-from hospital to community." Journal of wound, ostomy, and continence nursing 40.1 (2013): 101-3.
description	12.	Lo, Hubing S. "Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance." Nature communications 3.1 (2012): 724-724.
description	13.	Bollag, Hirth P. "Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma." Nature 467.7315 (2010): 596-599.
description	14.	Palanisamy, N. "Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma." Nature Medicine 16.7 (2010): 793-8.
description	15.	Miller, A. "Mechanisms of disease - Melanoma." New England Journal of Medicine, The 355.1 (2006): 51-65.
description	16.	Mardis, Elaine J. "Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome." New England Journal of Medicine, The 361.11 (2009): 1058-1066.
description	17.	Bleeker, Fonnet E. "IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors." Human Mutation 30.1 (2009): 7-11.
description	18.	Breslow, A. "Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma." Annals of surgery 172.5 (1970): 902-8.
description	19.	Hong-Mei, Z. "Mitogen-induced recruitment of ERK and MSK to SRE promoter complexes by ternary complex factor Elk-1." Nucleic acids symposium series 36.8 (2008): 2594-2607.
description	20.	Bentivegna, S. "Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD)." Human mutation 29.3 (2008): 441-450.